Performance of a Standardized Retrograde Urethrogram to Optimize Length, Segment, Etiology (LSE) Anterior Urethral Stricture Disease Classification and Staging.
Urology. 2026 Mar; 209(Mar):11-14. doi: 10.1016/j.urology.2025.11.247. pii: S0090-4295(25)01333-0.
Base: PUBMEDLatin American Consensus for the Diagnosis and Treatment of Metastatic Castration-Sensitive Prostate Cancer.
Clinical genitourinary cancer. 2026 Mar; 102538. doi: 10.1016/j.clgc.2026.102538. pii: S1558-7673(26)00038-8.
Base: PUBMEDVasectomy: AUA Guideline (2026) Part I.
The Journal of urology. 2026 Mar; 215(Mar):240-249. doi: 10.1097/JU.0000000000004861. pii: .
Base: PUBMEDGuideline of guidelines: management of small testicular masses.
BJU international. 2026 Mar; 137(Mar):444-453. doi: 10.1111/bju.70131. pii: .
Base: PUBMEDThe current landscape of single-port robotic surgery in urology.
Nature reviews. Urology. 2026 Mar; 23(Mar):156-173. doi: 10.1038/s41585-025-01081-z. pii: .
Base: PUBMEDSurgical Management of Kidney and Ureteral Stones: AUA Guideline (2026). Part III: Treatment of Patients With Kidney and/or Ureteral Stones and Future Directions.
The Journal of urology. 2026 Feb; 215(Feb):132-141. doi: 10.1097/JU.0000000000004844. pii: .
Base: PUBMEDInfection Prophylaxis in Urological Diagnostic and Surgical Procedures - A narrative review and recommendations.
International braz j urol : official journal of the Brazilian Society of Urology. 2025 ; 51():doi: 10.1590/S1677-5538.IBJU.2025.0333. pii: e20250333.
Base: PUBMEDModern integrative prostate cancer diagnostics.
Current opinion in urology. 2026 Mar; 36(Mar):171-179. doi: 10.1097/MOU.0000000000001361. pii: .
Base: PUBMEDRisk-Stratified Evaluation of Asymptomatic Microscopic Hematuria in Women: Clinical Implications of New Guidelines.
Urogynecology (Philadelphia, Pa.). 2026 Mar; doi: 10.1097/SPV.0000000000001838. pii: .
Base: PUBMEDWatt's the difference? A randomised trial of high- vs low-power ureteroscopic thulium fibre laser lithotripsy.
BJU international. 2026 Mar; 137(Mar):485-492. doi: 10.1111/bju.70123. pii: .
Base: PUBMEDEvolving Treatments and Resistance Mechanisms in Prostate Cancer Therapeutics.
ACS pharmacology & translational science. 2026 Apr; 9(Apr):815-838. doi: 10.1021/acsptsci.5c00757. pii: .
Base: PUBMEDUrinary incontinence during pregnancy and in the postpartum period.
Nature reviews. Urology. 2026 Mar; 23(Mar):184-195. doi: 10.1038/s41585-025-01091-x. pii: .
Base: PUBMEDState-of-the-Art Review: Diagnosis and Management of Acute and Chronic Bacterial Prostatitis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2026 Feb; 82(Feb):1-13. doi: 10.1093/cid/ciaf483. pii: .
Base: PUBMEDCombination Strategies to Enhance Bacillus Calmette-Guérin Efficacy for Nonmuscle-Invasive Bladder Cancer.
The Journal of urology. 2026 Mar; 215(Mar):264-275. doi: 10.1097/JU.0000000000004848. pii: .
Base: PUBMEDPerioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.
The New England journal of medicine. 2026 Apr; 394(Apr):1257-1269. doi: 10.1056/NEJMoa2511674. pii: .
Base: PUBMEDArtificial Intelligence-Based Recognition of the Prostatic Capsule During Nerve-Sparing Robot-Assisted Radical Prostatectomy.
International journal of urology : official journal of the Japanese Urological Association. 2026 Apr; 33(Apr):e70454. doi: 10.1111/iju.70454. pii: .
Base: PUBMEDImpact of PSMA PET on the management and clinical outcomes of patients with biochemical failure of prostate cancer after definitive treatment: a systematic review and meta-analysis.
International urology and nephrology. 2026 Mar; doi: 10.1007/s11255-026-05109-0. pii: .
Base: PUBMEDWhat Is Prostatitis?
JAMA. 2026 Mar; 335(Mar):918. doi: 10.1001/jama.2025.20559. pii: .
Base: PUBMEDTesticular germ cell tumors and molecular biomarkers.
Current opinion in urology. 2026 Mar; 36(Mar):205-211. doi: 10.1097/MOU.0000000000001353. pii: .
Base: PUBMEDA rapid evidence assessment for extracorporeal magnetic stimulation to treat urinary incontinence in men.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2026 Feb; 20(Feb):63-70. doi: 10.5489/cuaj.9320. pii: .
Base: PUBMEDProstate cancer.
Lancet (London, England). 2026 Feb; 407(Feb):622-636. doi: 10.1016/S0140-6736(25)02221-4. pii: S0140-6736(25)02221-4.
Base: PUBMEDRecent advances in urologic surgical pathology and molecular biomarker testing.
Current opinion in urology. 2026 Mar; 36(Mar):135-137. doi: 10.1097/MOU.0000000000001368. pii: .
Base: PUBMEDHistologic subtypes of urothelial carcinoma: an update.
Current opinion in urology. 2026 Mar; 36(Mar):138-146. doi: 10.1097/MOU.0000000000001358. pii: .
Base: PUBMEDA Review of Prostatitis.
JAMA. 2026 Feb; 335(Feb):459. doi: 10.1001/jama.2025.21097. pii: .
Base: PUBMEDSentinel lymph node staging in urological cancer surgery: advances in imaging, intra-operative detection and translational research.
BJU international. 2025 Dec; 136(Dec):979-989. doi: 10.1111/bju.16848. pii: .
Base: PUBMEDSummary of the clinical practice guideline for the management of urinary stones, third edition.
International journal of urology : official journal of the Japanese Urological Association. 2025 May; 32(May):462-474. doi: 10.1111/iju.70004. pii: .
Base: PUBMEDConsensus position statement on advancing the classification of patients and tests of cure in studies of antibiotic treatment of complicated urinary tract infections.
The Lancet. Infectious diseases. 2025 Oct; 25(Oct):e605-e618. doi: 10.1016/S1473-3099(25)00142-2. pii: S1473-3099(25)00142-2.
Base: PUBMEDUpdate and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children.
Journal of pediatric urology. 2025 Jun; doi: 10.1016/j.jpurol.2025.06.016. pii: S1477-5131(25)00321-3.
Base: PUBMEDThe AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause.
The Journal of urology. 2025 Sep; 214(Sep):242-250. doi: 10.1097/JU.0000000000004589. pii: .
Base: PUBMEDMultiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee.
European urology. 2025 Oct; doi: 10.1016/j.eururo.2025.10.010. pii: S0302-2838(25)04769-4.
Base: PUBMEDMale Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach.
The Journal of urology. 2025 Aug; 214(Aug):116-126. doi: 10.1097/JU.0000000000004564. pii: .
Base: PUBMEDMale Chronic Pelvic Pain: AUA Guideline: Part II Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
The Journal of urology. 2025 Aug; 214(Aug):127-137. doi: 10.1097/JU.0000000000004565. pii: .
Base: PUBMEDEuropean Association of Urology-European Society of Paediatric Urology Guidelines on Paediatric Urology: Summary of 2024 Updates. Part II.
European urology. 2025 Aug; 88(Aug):190-203. doi: 10.1016/j.eururo.2025.02.022. pii: S0302-2838(25)00144-7.
Base: PUBMEDEuropean Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie's Disease.
European urology. 2025 Jul; 88(Jul):76-102. doi: 10.1016/j.eururo.2025.04.010. pii: S0302-2838(25)00211-8.
Base: PUBMEDInternational Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The Prostate.
The American journal of surgical pathology. 2025 Jun; doi: 10.1097/PAS.0000000000002430. pii: .
Base: PUBMEDEuropean Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines.
European urology. 2025 May; 87(May):582-600. doi: 10.1016/j.eururo.2025.02.019. pii: S0302-2838(25)00138-1.
Base: PUBMEDUpdated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma.
European urology. 2025 Apr; 87(Apr):491-496. doi: 10.1016/j.eururo.2025.01.014. pii: S0302-2838(25)00026-0.
Base: PUBMEDManagement of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
European urology. 2025 Feb; 87(Feb):157-216. doi: 10.1016/j.eururo.2024.09.017. pii: S0302-2838(24)02610-1.
Base: PUBMEDUpdates to Incontinence After Prostate Treatment: AUA/GURS/SUFU Guideline (2024).
The Journal of urology. 2024 Oct; 212(Oct):531-538. doi: 10.1097/JU.0000000000004088. pii: .
Base: PUBMEDMetabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: An EAU Guidelines Update.
European urology. 2024 Oct; 86(Oct):343-363. doi: 10.1016/j.eururo.2024.05.029. pii: S0302-2838(24)02411-4.
Base: PUBMEDProstate Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Apr; 22(Apr):140-150. doi: 10.6004/jnccn.2024.0019. pii: .
Base: PUBMEDThe AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder.
The Journal of urology. 2024 Jul; 212(Jul):11-20. doi: 10.1097/JU.0000000000003985. pii: .
Base: PUBMEDSummary of the 2024 Update of the European Association of Urology Guidelines on Neurourology.
European urology. 2024 Jun; 85(Jun):543-555. doi: 10.1016/j.eururo.2024.03.026. pii: S0302-2838(24)02253-X.
Base: PUBMEDSummary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms.
European urology. 2024 Sep; 86(Sep):213-220. doi: 10.1016/j.eururo.2024.04.004. pii: S0302-2838(24)02273-5.
Base: PUBMEDPost-prostatectomy incontinence: a guideline of guidelines.
BJU international. 2024 May; 133(May):513-523. doi: 10.1111/bju.16233. pii: .
Base: PUBMEDEAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.
European urology. 2024 Aug; 86(Aug):148-163. doi: 10.1016/j.eururo.2024.03.027. pii: S0302-2838(24)02254-1.
Base: PUBMED2024 Canadian Urological Association guideline: Female stress urinary incontinence.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2024 Apr; 18(Apr):83-102. doi: 10.5489/cuaj.8751. pii: .
Base: PUBMEDEuropean Association of Urology Guidelines on Penile Size Abnormalities and Dysmorphophobia: Summary of the 2023 Guidelines.
European urology focus. 2023 Sep; doi: 10.1016/j.euf.2023.08.012. pii: S2405-4569(23)00197-9.
Base: PUBMEDEuropean Association of Urology Guidelines on the Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 2: Underactive Bladder, Bladder Outlet Obstruction, and Nocturia.
European urology. 2022 Jul; 82(Jul):60-70. doi: 10.1016/j.eururo.2022.01.044. pii: S0302-2838(22)01601-3.
Base: PUBMEDEuropean Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence.
European urology. 2022 Jul; 82(Jul):49-59. doi: 10.1016/j.eururo.2022.01.045. pii: S0302-2838(22)01603-7.
Base: PUBMEDEvolving Treatments and Resistance Mechanisms in Prostate Cancer Therapeutics.
ACS pharmacology & translational science. 2026 Apr; 9(Apr):815-838. doi: 10.1021/acsptsci.5c00757. pii: .
Base: PUBMEDPerioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.
The New England journal of medicine. 2026 Apr; 394(Apr):1257-1269. doi: 10.1056/NEJMoa2511674. pii: .
Base: PUBMEDArtificial Intelligence-Based Recognition of the Prostatic Capsule During Nerve-Sparing Robot-Assisted Radical Prostatectomy.
International journal of urology : official journal of the Japanese Urological Association. 2026 Apr; 33(Apr):e70454. doi: 10.1111/iju.70454. pii: .
Base: PUBMEDImpact of PSMA PET on the management and clinical outcomes of patients with biochemical failure of prostate cancer after definitive treatment: a systematic review and meta-analysis.
International urology and nephrology. 2026 Mar; doi: 10.1007/s11255-026-05109-0. pii: .
Base: PUBMEDRisk-Stratified Evaluation of Asymptomatic Microscopic Hematuria in Women: Clinical Implications of New Guidelines.
Urogynecology (Philadelphia, Pa.). 2026 Mar; doi: 10.1097/SPV.0000000000001838. pii: .
Base: PUBMEDLatin American Consensus for the Diagnosis and Treatment of Metastatic Castration-Sensitive Prostate Cancer.
Clinical genitourinary cancer. 2026 Mar; 102538. doi: 10.1016/j.clgc.2026.102538. pii: S1558-7673(26)00038-8.
Base: PUBMEDWhat Is Prostatitis?
JAMA. 2026 Mar; 335(Mar):918. doi: 10.1001/jama.2025.20559. pii: .
Base: PUBMEDRecent advances in urologic surgical pathology and molecular biomarker testing.
Current opinion in urology. 2026 Mar; 36(Mar):135-137. doi: 10.1097/MOU.0000000000001368. pii: .
Base: PUBMEDHistologic subtypes of urothelial carcinoma: an update.
Current opinion in urology. 2026 Mar; 36(Mar):138-146. doi: 10.1097/MOU.0000000000001358. pii: .
Base: PUBMEDIntraoperative assessment of surgical margins during radical prostatectomy: advances and challenges.
Current opinion in urology. 2026 Mar; 36(Mar):180-186. doi: 10.1097/MOU.0000000000001359. pii: .
Base: PUBMED